Study of Pegylated Human Recombinant Arginase for Liver Cancer (BCT-100-002)

NCT01092091 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasm
Hepatocellular Carcinoma

Interventions

BIOLOGICAL: Pegylated Recombinant Human Arginase I

Sponsor

Bio-Cancer Treatment International Limited

Collaborators

[object Object]
[object Object]